A carregar...
Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
Venetoclax – a novel, orally bioavailable inhibitor of B-cell lymphoma-2 – has demonstrated substantial clinical activity in the treatment of chronic lymphocytic leukemia. Alone or in combination with other targeted agents, venetoclax results in high rate of durable responses and undetectable measur...
Na minha lista:
| Publicado no: | Int J Hematol Oncol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689538/ https://ncbi.nlm.nih.gov/pubmed/33294171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2020-0010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|